ArticleOncoTargets and therapy2020

S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling.

Zhonghua Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.